About Emendo Biotherapeutics
Emendo Biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.
We leverage our expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottleneck of the field.
|
|
|
51-200 employees
View all Emendo Biotherapeutics employees
|
|
Biotechnology
|
|
400w E 61st St, New York, New York 10065, US
|
|
2015
|
Emendo Biotherapeutics Alternatives
Frequently Asked Questions about Emendo Biotherapeutics
David Baram is the CEO of Emendo Biotherapeutics. To contact David Baram email at [email protected]. Or you may call +972.544907749
The decision makers in Emendo Biotherapeutics are Idit Buch, Keren Farin, Liat Rockah, etc. Click to Find Emendo Biotherapeutics decision makers emails.
Emendo Biotherapeutics Staff Directory
Search Emendo Biotherapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
